Browse By Cell Line Result Page of OvirusTdb

The total number of records retrieved from this search are 16. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_763AdenovirusSG611DNAAdenoviridaeNoneYesNoNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman acute promyelocytic leukemic cell lineNB41.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay10 MOI99% cancer cell viability at 96 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_764AdenovirusSG611DNAAdenoviridaeNoneYesNoNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman acute promyelocytic leukemic cell lineNB41.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay40 MOI76% cancer cell viability at 96 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_765AdenovirusSG611DNAAdenoviridaeNoneYesNoNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman acute promyelocytic leukemic cell lineNB41.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay80 MOI64% cancer cell viability at 96 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_766AdenovirusSG611DNAAdenoviridaeNoneYesNoNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman acute promyelocytic leukemic cell lineNB41.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay120 MOI60% cancer cell viability at 96 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_767AdenovirusSG611DNAAdenoviridaeNoneYesNoNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman acute promyelocytic leukemic cell lineNB41.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay160 MOI52% cancer cell viability at 96 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_793AdenovirusSG611-VSTM1DNAAdenoviridaeA VSTM1 gene expression cassette containing VSTM1 cDNA, cytomegalovirus promoter and SV40 polyA was inserted into the genome of SG611 to generate SG611-VSTM1YesNoNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman acute promyelocytic leukemic cell lineNB41.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay10 MOI99% cancer cell viability at 96 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_794AdenovirusSG611-VSTM1DNAAdenoviridaeA VSTM1 gene expression cassette containing VSTM1 cDNA, cytomegalovirus promoter and SV40 polyA was inserted into the genome of SG611 to generate SG611-VSTM1YesNoNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman acute promyelocytic leukemic cell lineNB41.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay40 MOI60% cancer cell viability at 96 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_795AdenovirusSG611-VSTM1DNAAdenoviridaeA VSTM1 gene expression cassette containing VSTM1 cDNA, cytomegalovirus promoter and SV40 polyA was inserted into the genome of SG611 to generate SG611-VSTM1YesNoNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman acute promyelocytic leukemic cell lineNB41.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay80 MOI49% cancer cell viability at 96 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_796AdenovirusSG611-VSTM1DNAAdenoviridaeA VSTM1 gene expression cassette containing VSTM1 cDNA, cytomegalovirus promoter and SV40 polyA was inserted into the genome of SG611 to generate SG611-VSTM1YesNoNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman acute promyelocytic leukemic cell lineNB41.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay120 MOI35% cancer cell viability at 96 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_797AdenovirusSG611-VSTM1DNAAdenoviridaeA VSTM1 gene expression cassette containing VSTM1 cDNA, cytomegalovirus promoter and SV40 polyA was inserted into the genome of SG611 to generate SG611-VSTM1YesNoNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman acute promyelocytic leukemic cell lineNB41.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay160 MOI30% cancer cell viability at 96 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_819AdenovirusSG611-VSTM1DNAAdenoviridaeA VSTM1 gene expression cassette containing VSTM1 cDNA, cytomegalovirus promoter and SV40 polyA was inserted into the genome of SG611 to generate SG611-VSTM1NoViral strain in combination with DNR 120 ng/mlNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman acute promyelocytic leukemic cell lineNB41.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay10 MOI64% cancer cell viability at 72 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_820AdenovirusSG611-VSTM1DNAAdenoviridaeA VSTM1 gene expression cassette containing VSTM1 cDNA, cytomegalovirus promoter and SV40 polyA was inserted into the genome of SG611 to generate SG611-VSTM1NoViral strain in combination with DNR 240 ng/mlNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman acute promyelocytic leukemic cell lineNB41.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay10 MOI55% cancer cell viability at 72 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_827AdenovirusSG611-VSTM1DNAAdenoviridaeA VSTM1 gene expression cassette containing VSTM1 cDNA, cytomegalovirus promoter and SV40 polyA was inserted into the genome of SG611 to generate SG611-VSTM1NoViral strain in combination with DNR 120 ng/mlNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman acute promyelocytic leukemic cell lineNB41.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay40 MOI50% cancer cell viability at 72 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_828AdenovirusSG611-VSTM1DNAAdenoviridaeA VSTM1 gene expression cassette containing VSTM1 cDNA, cytomegalovirus promoter and SV40 polyA was inserted into the genome of SG611 to generate SG611-VSTM1NoViral strain in combination with DNR 240 ng/mlNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman acute promyelocytic leukemic cell lineNB41.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay40 MOI42% cancer cell viability at 72 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_5542Herpes simplex virusMutantDNAHerpesviridaeDeletion mutatnt in TK gene and UL 24 geneYesNoNoATCCHuman medulloblastoma cell lineSNB40NANANA0.001 MOIAll cells was dead after 4 daysNoNoNA No responseNANANANAUS6770274
OV_5543Herpes simplex virusMutantDNAHerpesviridaeDeletion mutatnt in TK gene and UL 24 geneYesNoNoATCCHuman medulloblastoma cell lineSNB40NANANA0.1 MOIAll cells was dead after 4 daysNoNoNA No responseNANANANAUS6770274